These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 9300249

  • 1. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
    Burgos R, Simó R, Audí L, Mateo C, Mesa J, García-Ramírez M, Carrascosa A.
    Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
    [Abstract] [Full Text] [Related]

  • 2. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X, Wang G, Wang Y.
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [Abstract] [Full Text] [Related]

  • 3. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
    Hernández C, Burgos R, Cantón A, García-Arumí J, Segura RM, Simó R.
    Diabetes Care; 2001 Mar; 24(3):516-21. PubMed ID: 11289478
    [Abstract] [Full Text] [Related]

  • 4. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R, Mediero A, Martínez-Montero JC, Roldán-Pallarés M, Suárez-Leoz M, Vidal-Fernández P, Cortés-Valdés C, Fernández-Cruz A, Fernández-Durango R.
    Mol Vis; 2004 Jul 15; 10():450-7. PubMed ID: 15273657
    [Abstract] [Full Text] [Related]

  • 5. [A comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy].
    Zhou H, Zhang H.
    Zhonghua Yan Ke Za Zhi; 1997 Jul 15; 33(4):247-50. PubMed ID: 10451953
    [Abstract] [Full Text] [Related]

  • 6. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H.
    Ophthalmology; 2008 Nov 15; 115(11):1916-22. PubMed ID: 18718666
    [Abstract] [Full Text] [Related]

  • 7. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
    Fosmark DS, Bragadóttir R, Stene-Johansen I, Berg JP, Berg TJ, Lund T, Sandvik L, Hanssen KF.
    Acta Ophthalmol Scand; 2007 Sep 15; 85(6):618-22. PubMed ID: 17488318
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
    Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE.
    N Engl J Med; 1994 Dec 01; 331(22):1480-7. PubMed ID: 7526212
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM, Polak BC, Reichert-Thoen JW, de Vries-Knoppert WA, van Hinsbergh VW, Tangelder GJ.
    Diabetologia; 2002 Feb 01; 45(2):203-9. PubMed ID: 11935151
    [Abstract] [Full Text] [Related]

  • 10. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
    Simó R, Hernández C, Segura RM, García-Arumí J, Sararols L, Burgos R, Cantón A, Mesa J.
    Clin Sci (Lond); 2003 Mar 01; 104(3):223-30. PubMed ID: 12605576
    [Abstract] [Full Text] [Related]

  • 11. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI, Tombran-Tink J, Hykin PG, Gregor ZJ, Cree IA.
    Exp Eye Res; 2006 May 01; 82(5):798-806. PubMed ID: 16324700
    [Abstract] [Full Text] [Related]

  • 12. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H, Kishi S, Kotajima N, Murakami M.
    Ophthalmology; 2004 Oct 01; 111(10):1880-4. PubMed ID: 15465550
    [Abstract] [Full Text] [Related]

  • 13. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gibson JM, Lip GY.
    Invest Ophthalmol Vis Sci; 2000 Jul 01; 41(8):2115-9. PubMed ID: 10892852
    [Abstract] [Full Text] [Related]

  • 14. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D, Suzuma K, Suzuma I, Ohashi H, Ojima T, Kurimoto M, Murakami T, Kimura T, Takagi H.
    Am J Ophthalmol; 2005 Mar 01; 139(3):476-81. PubMed ID: 15767056
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C, Lecube A, Segura RM, Sararols L, Simó R.
    Diabet Med; 2002 Aug 01; 19(8):655-60. PubMed ID: 12147146
    [Abstract] [Full Text] [Related]

  • 16. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Simó R, Lecube A, Segura RM, García Arumí J, Hernández C.
    Am J Ophthalmol; 2002 Sep 01; 134(3):376-82. PubMed ID: 12208249
    [Abstract] [Full Text] [Related]

  • 17. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M, Kabatas EU, Batman C, Akin KO, Kabatas N.
    Ophthalmic Res; 2012 Sep 01; 47(1):7-12. PubMed ID: 21691136
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C, Segura RM, Fonollosa A, Carrasco E, Francisco G, Simó R.
    Diabet Med; 2005 Jun 01; 22(6):719-22. PubMed ID: 15910622
    [Abstract] [Full Text] [Related]

  • 19. Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells.
    Hirata C, Nakano K, Nakamura N, Kitagawa Y, Shigeta H, Hasegawa G, Ogata M, Ikeda T, Sawa H, Nakamura K, Ienaga K, Obayashi H, Kondo M.
    Biochem Biophys Res Commun; 1997 Jul 30; 236(3):712-5. PubMed ID: 9245719
    [Abstract] [Full Text] [Related]

  • 20. Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines.
    Funatsu H, Yamashita H, Mimura T, Noma H, Nakamura S, Hori S.
    Eye (Lond); 2007 Mar 30; 21(3):377-82. PubMed ID: 16410812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.